ARMGO Pharma

ARMGO Pharma, Inc. is a biopharmaceutical company developing small-molecule therapies to treat debilitating cardiac, skeletal muscle, and neurological disorders. It provides rycals, which are calcium release channel stabilizers acting on ryanodine receptors/calcium release channels located in the sarcoplasmic/endoplasmic reticulum of cells for the treatment of chronic heart failure, arrhythmias, and muscular disorders, as well as cognitive impairment, malignant hyperthermia, diabetes, chronic obstructive pulmonary disease, hypertension, and bladder dysfunction.